Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
BACKGROUND & AIMS Both hepatic resection and radiofrequency ablation (RFA) are considered curative treatments for hepatocellular carcinoma (HCC), but their economic impact still remains not determined. Aim of the present study was to analyze the cost-effectiveness (CE) of these two strategies in early stage HCC (Milan criteria). METHODS As first step, a meta-analysis of the pertinent literature of the last decade was performed. Seventeen studies fulfilled the inclusion criteria: 3996 patients underwent resection and 4424 underwent RFA for early HCC. Data obtained from the meta-analysis were used to construct a Markov model. Costs were assessed from the health care provider perspective. A Monte Carlo probabilistic sensitivity analysis was used to estimate outcomes with distribution samples of 1000 patients for each treatment arm. RESULTS In a 10-year perspective, for very early HCC (single nodule <2 cm) in Child-Pugh class A patients, RFA provided similar life-expectancy and quality-adjusted life-expectancy at a lower cost than resection and was the most cost-effective therapeutic strategy. For single HCCs of 3-5 cm, resection provided better life-expectancy and was more cost-effective than RFA, at a willingness-to-pay above €4200 per quality-adjusted life-year. In the presence of two or three nodules ≤3 cm, life-expectancy and quality-adjusted life-expectancy were very similar between the two treatments, but cost-effectiveness was again in favour of RFA. CONCLUSIONS For very early HCC and in the presence of two or three nodules ≤3 cm, RFA is more cost-effective than resection; for single larger early stage HCCs, surgical resection remains the best strategy to adopt as a result of better survival rates at an acceptable increase in cost.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“0 2 Journal of Hepatology 201 and DerSimonian and Laird [13,14].”
BackgroundQuantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Self-citationEstimating the mean and variance from the median, range, and the size of a sample
Hozo, S. P., Djulbegovic, B., & Hozo, I. (2005) · BMC Medical Research Methodology · doi:10.1186/1471-2288-5-13 · Cited by 9,062
Management of Hepatocellular Carcinoma: An Update Δσ
Bruix, J., & Sherman, M. (2011) · Hepatology · doi:10.1002/hep.24199 · Cited by 8,103
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
Forner, A., Llovet, J. M., & Bruix, J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61347-0 · Cited by 4,022
D'Amico, G., Garcia-Tsao, G., & Pagliaro, L. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.10.013 · Cited by 2,687
Llovet, J. M., Ducreux, M. P., Lencioni, R. A., Bisceglie, A. M. D., Dufour, J., Greten, T. F., Raymond, É., Roskams, T., Mazzaferro, V., Bruix, J., et al. (2012) · Cited by 1,488
Chen, M.-S., Li, J.-Q., Zheng, Y., Guo, R.-P., Liang, H.-H., Zhang, Y.-Q., Lin, X.-J., & Lau, W. Y. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000201480.65519.b8 · Cited by 1,432
Recommendations for Reporting Cost-effectiveness Analyses
Siegel, J. E. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540160061034 · Cited by 1,147
Livraghi, T., Meloni, F., Di Stasi, M., Rolle, E., Solbiati, L., Tinelli, C., & Rossi, S. (2008) · Hepatology · doi:10.1002/hep.21933 · Cited by 1,103
Siegel, J. E. (1996) · JAMA · doi:10.1001/jama.276.16.1339 · Cited by 1,037
Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions
Fenwick, E., O'Brien, B. J., & Briggs, A. (2004) · Health Economics · doi:10.1002/hec.903 · Cited by 943
American Association for the Study of Liver Diseases
Popper, H. (1960) · Gastroenterology · doi:10.1016/s0016-5085(60)80094-7 · Cited by 903
Huang, J., Yan, L., Cheng, Z., Wu, H., Du, L., Wang, J., Xu, Y., & Zeng, Y. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181efc656 · Cited by 844
Feng, K., Yan, J., Li, X., Xia, F., Ma, K., Wang, S., Bie, P., & Dong, J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.05.007 · Cited by 767
de Lope, C. R., Tremosini, S., Forner, A., Reig, M., & Bruix, J. (2012) · Journal of Hepatology · doi:10.1016/s0168-8278(12)60009-9 · Cited by 610
Panel on cost-effectiveness in health and medicine.
Gold, M. (1996) · PubMed · Cited by 492
Prospective Analysis of Risk Factors for Hepatocellular Carcinoma in Patients With Liver Cirrhosis
Velázquez, R. F., Rodríguez, M., Navascués, C. A., Linares, A., Pérez, R., Sotorríos, N. G., Martínez, I., & Rodrigo, L. (2003) · Hepatology · doi:10.1053/jhep.2003.50093 · Cited by 440
Wang, J.-H., Wang, C.-C., Hung, C.-H., Chen, C.-L., & Lu, S.-N. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.05.020 · Cited by 348
Germani, G., Pleguezuelo, M., Gurusamy, K., Meyer, T., Isgrò, G., & Burroughs, A. K. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.12.004 · Cited by 304
Vivarelli, M., Guglielmi, A., Ruzzenente, A., Cucchetti, A., Bellusci, R., Cordiano, C., & Cavallari, A. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000129672.51886.44 · Cited by 256
Self-citationIs Portal Hypertension a Contraindication to Hepatic Resection?
Cucchetti, A., Ercolani, G., Vivarelli, M., Cescon, M., Ravaioli, M., Ramacciato, G., Grazi, G. L., & Pinna, A. D. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181b977a5 · Cited by 244
Self-citationPeng, Z.-W., Lin, X.-J., Zhang, Y.-J., Liang, H.-H., Guo, R.-P., Shi, M., & Chen, M.-S. (2012) · Radiology · doi:10.1148/radiol.11110817 · Cited by 238
Hong, S. N., Lee, S.-Y., Choi, M. S., Lee, J. H., Koh, K. C., Paik, S. W., Yoo, B. C., Rhee, J. C., Choi, D., Lim, H. K., et al. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000152746.72149.31 · Cited by 222
Indexes and boundaries for “quantitative significance” in statistical decisions
Burnand, B., Kernan, W. N., & Feinstein, A. R. (1990) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(90)90093-5 · Cited by 209
Systematic Review: Health-State Utilities in Liver Disease: A Systematic Review
McLernon, D. J., Dillon, J., & Donnan, P. T. (2008) · Medical Decision Making · doi:10.1177/0272989x08315240 · Cited by 165
Hasegawa, K., Makuuchi, M., Takayama, T., Kokudo, N., Arii, S., Okazaki, M., Okita, K., Omata, M., Kudo, M., Kojiro, M., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.05.018 · Cited by 162
Guglielmi, A., Ruzzenente, A., Valdegamberi, A., Pachera, S., Campagnaro, T., D’Onofrio, M., Martone, E., Nicoli, P., & Iacono, C. (2007) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-007-0392-8 · Cited by 149
Séror, O., Nkontchou, G., Ibraheem, M., et al. (2008) · Radiology · doi:10.1148/radiol.2481071101 · Cited by 124
For The Kagoshima Liver Cancer Study Group, Ueno, S., Sakoda, M., Kubo, F., Hiwatashi, K., 立野, 太., Baba, Y., Hasegawa, S., & Tsubouchi, H. (2009) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-009-0069-7 · Cited by 121
Montorsi, M., Santambrogio, R., Bianchi, P. P., Donadon, M., Moroni, E., Spinelli, A., & Costa, M. (2004) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2004.10.003 · Cited by 120
Hilal, M. A., Primrose, J. M., Casaril, A., McPhail, M. J. W., Pearce, N. W., & Nicoli, N. (2008) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-008-0553-4 · Cited by 117
The changing scenario of hepatocellular carcinoma over the last two decades in Italy
Santi, V., Buccione, D., Micoli, A. D., Fatti, G., Frigerio, M., Farinati, F., Poggio, P. D., Rapaccini, G., Nolfo, M. A. D., Benvegnù, L., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.05.026 · Cited by 96
Nishikawa, H., Inuzuka, T., Takeda, H., Nakajima, J., Matsuda, F., Sakamoto, A., Henmi, S., Hatamaru, K., Ishikawa, T., Saito, S., et al. (2011) · BMC Gastroenterology · doi:10.1186/1471-230x-11-143 · Cited by 95
Hiraoka, A., Horiike, N., Yamashita, Y., Koizumi, Y., Doi, K., Yamamoto, Y., Hasebe, A., Ichikawa, S., Yano, M., Miyamoto, Y., et al. (2008) · PubMed · Cited by 82
Single HCC smaller than 2 cm: surgery or ablation?
Takayama, T., Makuuchi, M., & Hasegawa, K. (2009) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1007/s00534-009-0239-7 · Cited by 68
Cho, C. M., Tak, W. Y., Kweon, Y.-O., Kim, S.-K., Choi, Y.-H., Hwang, Y.-J., & Kim, Y.-I. (2005) · PubMed · Cited by 49
Partial hepatectomy versus radiofrequency ablation for hepatocellular carcinoma
Majno, P. E., Mentha, G., & Mazzaferro, V. (2010) · Hepatology · doi:10.1002/hep.23648 · Cited by 39
Cited by
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Self-citationForner, A., Reig, M., & Bruix, J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30010-2 · Cited by 5,531
Villanueva, A. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1713263 · Cited by 4,508
BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update
Reig, M., Forner, A., Rimola, J., Ferrer-Fàbrega, J., Burrel, M., Garcia-Criado, Á., Kelley, R. K., Galle, P. R., Mazzaferro, V., Salem, R., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.11.018 · Cited by 4,319
Omata, M., Cheng, A.-L., Kokudo, N., Kudo, M., Lee, J. M., Jia, J., Tateishi, R., Han, K.-H., Chawla, Y. K., Shiina, S., et al. (2017) · Hepatology International · doi:10.1007/s12072-017-9799-9 · Cited by 2,171
Metadata
- Authors
- Cucchetti, A., Piscaglia, F., Cescon, M., Colecchia, A., Ercolani, G., Bolondi, L., & Pinna, A. D.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 59
- Issue
- 2
- Pages
- 300-307
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2032349276
- Cited by
- 407
- References
- 42
- FWCI
- 12.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.